CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Principal Accounting Officer sold 5,910 shares at $2.50 ($14,756)
- 4 Open-market sale Principal Financial Officer sold 15,842 shares at $2.50 ($39,554)
- 4 Open-market sale President and Head of R&D sold 23,638 shares at $2.50 ($59,019)
- 4 Open-market sale Chief Executive Officer sold 51,562 shares at $2.50 ($128,740)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 14,000 shares at $2.36 ($32,998)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and Head of R&D acquired 54,725 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 137,125 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 32 · 631 filings